Ovid Therapeutics Inc.
OVID | NASDAQ
$2.71
+$0.02 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$2.71
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:22 AM ET
Market Data
Market Cap $505.79M
Enterprise Value $401.29M
Beta 0.25
Average Volume 2.11M
Shares Outstanding (Diluted) 197.45M
Shares Change YoY 177.67%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US6904691010
Price Performance
Price Change 1M -1.4%
Price Change 3M 16.8%
Price Change 6M 12.9%
Price Change YTD 54.0%
Price Change 1Y 110.1%
Price Change 3Y -25.6%
Price Change 5Y -21.4%
1M CAGR (ann.) 3.0%
1Y CAGR (ann.) 122.1%
5Y CAGR (ann.) -4.9%
All-Time CAGR -14.8%
Valuation
PE Ratio -7.53
Forward PE N/A
PEG Ratio 0.16
Forward PEG -0.57
PS Ratio 319.52
Forward PS 1,585.60
PB Ratio 2.41
P/FCF Ratio -9.23
P/Adj. FCF Ratio -8.81
P/OCF Ratio -3.66
EV/Sales 253.50
EV/EBIT -11.19
EV/EBITDA -11.21
EV/FCF -7.33
Earnings Yield -13.3%
FCF Yield -10.8%
Adj. FCF Yield -11.3%
Financial Health
Net Cash $117.22M
Total Debt $12.72M
Cash & Short-Term Investments $117.22M
Total Assets $231.97M
Current Ratio 12.39
Quick Ratio 12.39
Debt / Equity Ratio 0.06
Debt / EBITDA -0.36
Debt / FCF -0.23
OCF / Debt -4.31
Interest Coverage 0.00
Altman Z-Score 11.69
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -3686.7%
EBITDA Margin -2252.4%
Net Profit Margin -2178.9%
FCF Margin -3460.1%
Adj. FCF Margin -3626.0%
SBC / Revenue 165.9%
SBC Impact (per share) -4.8%
Returns
Return on Assets -14.9%
Return on Equity -23.6%
Return on Invested Capital -26.1%
Return on Capital Employed -26.3%
Return on Tangible Assets -14.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 99.8%
Revenue CAGR 5Y -62.8%
Revenue CAGR 10Y -4.1%
EPS CAGR 3Y 7.9%
EPS CAGR 5Y 23.4%
EPS CAGR 10Y 24.3%
FCF CAGR 3Y -1.8%
FCF CAGR 5Y 2.3%
FCF CAGR 10Y -8.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 14
EPS Growth Next 3Y -2.8%
Revenue Growth Next 3Y 90.2%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.08
EPS Growth Est (next Q) -52.9%
Revenue Est (next Q) $17.75K
Revenue Growth Est (next Q) -86.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.50
Price Target Upside 139.9%
Cash Flow
Operating Cash Flow $-54.77M
Free Cash Flow $-54.77M
Adj. Free Cash Flow $-57.4M
FCF Per Share -$0.74
OCF Per Share -$0.74
OCF/S Ratio -3460.1%
Income Statement
Revenue $1.58M
Gross Profit $1.55M
Operating Income $-58.36M
EBITDA $-35.8M
Net Income $-34.49M
EPS (Diluted) -$0.36
Revenue / Employee $68.83K
Profit / Employee $-1.5M
Employees 23
Add to Watchlist
Select watchlists to add or remove OVID